查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1206631

溶瘤病毒治療市場:按病毒類型（基因重組溶瘤病毒,溶瘤野生型病毒）,應用（實體瘤,黑色素瘤）,最終用戶（醫院,專科診所,癌症研究所）地區2023-2028

Oncolytic Virus Therapies Market by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

到 2022 年，溶瘤病毒療法的全球市場規模將達到 1.304 億美元。 展望未來，IMARC Group 預計到 2028 年將達到 4.926 億美元，2023 年至 2028 年的增長率 (CAGR) 為 20.90%。

溶瘤病毒療法是一種使用病毒感染和破壞癌細胞的免疫療法。 使用多種天然和重組病毒，包括單純皰疹病毒,新城疫病毒,牛痘病毒,腺病毒,呼腸孤病毒和小核糖核酸病毒。 溶瘤病毒療法激活紅旗以產生免疫反應，並廣泛用於治療實體瘤,黑色素瘤和無法切除的疾病。 也可以使用僅感染和破壞目標腫瘤細胞的病毒來根除腫瘤。 溶瘤病毒療法無毒,高效，與化療相比可以延長癌症患者的生存期。 因此被廣泛應用於醫院,診所,腫瘤研究所等。

溶瘤病毒療法市場趨勢

  • 全球癌症發病率的上升為市場提供了光明的前景。 溶瘤病毒療法廣泛用於治療各種癌症，包括膠質母細胞瘤,乳腺癌,肺癌和前列腺癌，因為它具有強大的抗腫瘤特性，並且能夠在不傷害周圍組織的情況下精確靶向腫瘤。 與此同時，它廣泛用於治療不同類型的黑色素瘤，如血液惡性腫瘤,淋巴瘤,白血病和骨髓瘤，對市場的增長產生了積極影響。 此外，越來越多的患者擔心手術,放射療法,化學療法和免疫療法等各種癌症治療對健康的不利影響，也推動了市場的增長。 市場的增長也受到越來越多的溶瘤病毒臨床研究的推動，例如皰疹病毒,腺病毒和痘苗病毒，這些研究處於最後階段並顯示出出色的實驗結果。 對先進和新療法的需求不斷增加，以及多個政府加大力度傳播對各種癌症原因的認識並促進早期診斷等因素也推動了市場增長。預計將促進

主要市場細分

  • IMARC Group 分析了全球溶瘤病毒治療市場報告每個子部分的主要趨勢，以及 2023 年至 2028 年在全球,區域和國家層面的預測。 該報告根據病毒類型,應用程序和最終用途對市場進行分類。

按病毒類型分類

  • 重組溶瘤病毒
  • 單純皰疹病毒
  • 腺病毒
  • 牛痘病毒
  • 溶瘤野生型病毒
  • 呼腸孤病毒
  • 新城疫病毒
  • 大皰性口炎病毒

按應用細分

  • 實體癌
  • 乳腺癌
  • 前列腺癌
  • 肺癌
  • 膠質母細胞瘤
  • 黑色素瘤
  • 血液系統惡性腫瘤
  • 淋巴瘤
  • 白血病
  • 骨髓瘤

最終用戶細分

  • 醫院
  • 專科診所
  • 癌症研究所

按地區劃分

  • 北美
  • 美國
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳大利亞
  • 印度尼西亞
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

本報告中回答的關鍵問題

  • 1.2022 年全球溶瘤病毒治療市場的規模有多大？
  • 2. 2023-2028年全球溶瘤病毒治療市場的預期增長率是多少？
  • 3. 推動全球溶瘤病毒治療市場的關鍵因素是什麼？
  • 4.COVID-19 對全球溶瘤病毒市場有何影響？
  • 5. 全球溶瘤病毒治療市場的主要區域有哪些？
  • 6. 全球溶瘤病毒治療市場的主要參與者/公司有哪些？

內容

第一章前言

第 2 章研究方法和範圍

  • 調查的目的
  • 利益相關者
  • 數據來源
    • 主要信息
    • 次要信息
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章執行摘要

第四章介紹

  • 概覽
  • 主要行業趨勢

第 5 章溶瘤病毒療法的全球市場

  • 市場概覽
  • 市場結果
  • COVID-19 的影響
  • 市場預測

第 6 章按病毒類型劃分的市場細分

  • 重組溶瘤病毒
    • 市場趨勢
    • 主要細分市場
      • 單純皰疹病毒
      • 腺病毒
      • 牛痘病毒
    • 市場預測
  • 用於癌症治療的野生型病毒
    • 市場趨勢
    • 主要細分市場
      • 呼腸孤病毒
      • 新城疫病毒
      • 大皰性口炎病毒
    • 市場預測

第 7 章應用市場細分

  • 實體癌
    • 市場趨勢
    • 主要細分市場
      • 乳腺癌
      • 前列腺癌
      • 肺癌
      • 膠質母細胞瘤
    • 市場預測
  • 黑色素瘤
    • 市場趨勢
    • 主要細分市場
      • 血液系統惡性腫瘤
      • 淋巴瘤
      • 白血病
      • 骨髓瘤
    • 市場預測

第 8 章最終用戶市場細分

  • 醫院
    • 市場趨勢
    • 市場預測
  • 專科門診
    • 市場趨勢
    • 市場預測
  • 癌症研究所
    • 市場趨勢
    • 市場展望

第 9 章按區域劃分的市場細分

  • 北美
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場展望
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場展望
    • 日本
      • 市場趨勢
      • 市場展望
    • 印度
      • 市場趨勢
      • 市場展望
    • 韓國市場
      • 市場趨勢
      • 市場展望
    • 澳大利亞
      • 市場趨勢
      • 市場展望
    • 印度尼西亞
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場展望
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 意大利
      • 市場趨勢
      • 市場展望
    • 西班牙
      • 市場趨勢
      • 市場展望
    • 俄羅斯
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場展望
    • 墨西哥
      • 市場趨勢
      • 市場展望
    • 其他
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家/地區劃分的市場細分
    • 市場展望

第 10 章 SWOT 分析

  • 概覽
  • 強度
  • 弱點
  • 機會
  • 威脅

第11章價值鏈分析

第12章搬運工五力分析

  • 概覽
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

第14章競爭格局

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Amgen Inc.
    • Dnatrix Inc.
    • Genelux Corporation
    • Lokon Pharma AB
    • Replimune Group Inc.
    • Rigvir Ltd.
    • Sorrento Therapeutics
    • Takara Bio Inc.（Takara Holdings Inc.）
    • Targovax
    • TILT Biotherapeutics Ltd
    • Transgene SA
    • Vyriad

本報告中提及的公司名稱僅為部分，本報告中提及的所有公司名稱。

Product Code: SR1323A103_Report

The global oncolytic virus therapies market size reached US$ 130.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 492.6 Million by 2028, exhibiting a growth rate (CAGR) of 20.90% during 2023-2028.

Oncolytic virus therapies are a form of immunotherapy that utilizes viruses to infect and destroy cancer cells. They use various natural and genetically modified viruses, such as herpes simplex, Newcastle disease, vaccinia, adenovirus, reovirus, and picornavirus. Oncolytic virus therapies activate danger signals for generating an immune response and are widely used for treating solid tumors, melanoma, and unresectable lesions. They also help eradicate tumors using viruses that only infect and destroy targeted tumor cells. As compared to chemotherapy, oncolytic virus therapies are non-toxic, provide superior efficacy, and prolong the survival of cancer patients. As a result, they find extensive applications in hospitals, clinics, and cancer research institutes.

Oncolytic Virus Therapies Market Trends:

  • The rising incidences of cancer across the globe are creating a positive outlook for the market. Oncolytic virus therapies are widely used to treat various cancers, such as glioblastoma, breast, lung, and prostate cancers, due to their powerful anti-tumor properties and ability to target tumors accurately without harming surrounding tissues. In line with this, the widespread utilization of the therapy to treat various types of melanomas, such as hematological malignancies, lymphoma, leukemia, and myeloma, is favoring the market growth. Furthermore, rising concerns among patients regarding the negative health impact of various cancer treatments, such as surgical intervention, radiotherapy, chemotherapy, and immunotherapy, are providing a considerable boost to the market growth. Additionally, the rising number of clinical studies in oncolytic viruses, such as herpesvirus, adenovirus, and vaccinia virus, that is in the final stages and have demonstrated excellent experimental results are facilitating the market growth. Other factors, including rising demand for advanced treatments and novel therapies and increasing initiatives by several governments to spread awareness regarding different causes of cancer and promote early diagnosis, are anticipated to drive the market growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global oncolytic virus therapies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on virus type, application and end use.

Breakup by Virus Type:

  • Genetically Engineered Oncolytic Viruses
  • Herpes Simplex Virus
  • Adenovirus
  • Vaccinia Virus
  • Oncolytic Wild-Type Viruses
  • Reovirus
  • Newcastle Disease Virus
  • Vesicular Stomatitis Virus

Breakup by Application:

  • Solid Tumors
  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Glioblastoma
  • Melanoma
  • Hematological Malignancies
  • Lymphoma
  • Leukemia
  • Myeloma

Breakup by End Use:

  • Hospitals
  • Specialty Clinics
  • Cancer Research Institute

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Dnatrix Inc., Genelux Corporation, Lokon Pharma AB, Replimune Group Inc., Rigvir Ltd., Sorrento Therapeutics, Takara Bio Inc. (Takara Holdings Inc.), Targovax, TILT Biotherapeutics Ltd, Transgene SA and Vyriad. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • 1. What was the size of the global oncolytic virus therapies market in 2022?
  • 2. What is the expected growth rate of the global oncolytic virus therapies market during 2023-2028?
  • 3. What are the key factors driving the global oncolytic virus therapies market?
  • 4. What has been the impact of COVID-19 on the global oncolytic virus therapies market?
  • 5. What are the key regions in the global oncolytic virus therapies market?
  • 6. Who are the key players/companies in the global oncolytic virus therapies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncolytic Virus Therapies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Virus Type

  • 6.1 Genetically Engineered Oncolytic Viruses
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Herpes Simplex Virus
      • 6.1.2.2 Adenovirus
      • 6.1.2.3 Vaccinia Virus
    • 6.1.3 Market Forecast
  • 6.2 Oncolytic Wild-Type Viruses
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Reovirus
      • 6.2.2.2 Newcastle Disease Virus
      • 6.2.2.3 Vesicular Stomatitis Virus
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Solid Tumors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Breast Cancer
      • 7.1.2.2 Prostate Cancer
      • 7.1.2.3 Lung Cancer
      • 7.1.2.4 Glioblastoma
    • 7.1.3 Market Forecast
  • 7.2 Melanoma
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Hematological Malignancies
      • 7.2.2.2 Lymphoma
      • 7.2.2.3 Leukemia
      • 7.2.2.4 Myeloma
    • 7.2.3 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cancer Research Institute
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amgen Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Dnatrix Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Genelux Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Lokon Pharma AB
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Replimune Group Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Rigvir Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Sorrento Therapeutics
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Takara Bio Inc. (Takara Holdings Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Targovax
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 TILT Biotherapeutics Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Transgene SA
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Vyriad
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

  • Figure 1: Global: Oncolytic Virus Therapies Market: Major Drivers and Challenges
  • Figure 2: Global: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Oncolytic Virus Therapies Market: Breakup by Virus Type (in %), 2022
  • Figure 5: Global: Oncolytic Virus Therapies Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Oncolytic Virus Therapies Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Oncolytic Virus Therapies Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Oncolytic Virus Therapies (Solid Tumors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Oncolytic Virus Therapies (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Oncolytic Virus Therapies (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Oncolytic Virus Therapies (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Oncolytic Virus Therapies (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Oncolytic Virus Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Oncolytic Virus Therapies (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Oncolytic Virus Therapies (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: North America: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: North America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: United States: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: United States: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Canada: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Canada: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Asia-Pacific: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Asia-Pacific: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: China: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: China: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Japan: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Japan: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: India: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: India: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: South Korea: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: South Korea: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Australia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Australia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Indonesia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Indonesia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Europe: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Europe: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Germany: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Germany: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: France: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: France: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: United Kingdom: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: United Kingdom: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Italy: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Italy: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Spain: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Spain: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Russia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Russia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Latin America: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Latin America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Brazil: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Brazil: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Mexico: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Mexico: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Middle East and Africa: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Middle East and Africa: Oncolytic Virus Therapies Market: Breakup by Country (in %), 2022
  • Figure 70: Middle East and Africa: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Global: Oncolytic Virus Therapies Industry: SWOT Analysis
  • Figure 72: Global: Oncolytic Virus Therapies Industry: Value Chain Analysis
  • Figure 73: Global: Oncolytic Virus Therapies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncolytic Virus Therapies Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Virus Type (in Million US$), 2023-2028
  • Table 3: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Oncolytic Virus Therapies Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Oncolytic Virus Therapies Market: Competitive Structure
  • Table 7: Global: Oncolytic Virus Therapies Market: Key Players